136 related articles for article (PubMed ID: 16473243)
1. Imatinib as a cause of cystoid macular edema following uneventful phacoemulsification surgery.
Masood I; Negi A; Dua HS
J Cataract Refract Surg; 2005 Dec; 31(12):2427-8. PubMed ID: 16473243
[TBL] [Abstract][Full Text] [Related]
2. Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect.
Georgalas I; Pavesio C; Ezra E
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1585-6. PubMed ID: 17562067
[No Abstract] [Full Text] [Related]
3. Clinical course of macular edema in two cases of interferon-associated retinopathy observed by optical coherence tomography.
Shimura M; Saito T; Yasuda K; Tamai M
Jpn J Ophthalmol; 2005; 49(3):231-4. PubMed ID: 15944830
[TBL] [Abstract][Full Text] [Related]
4. [Psoriasis vulgaris exacerbated by imatinib therapy in chronic myelogenous leukemia].
Shimizu K; Kuroda H; Kida M; Watanabe H; Shirao S; Akiyama T; Fujimi A; Tanaka I; Sato T; Matsunaga T; Niitsu Y
Rinsho Ketsueki; 2005 Oct; 46(10):1152-5. PubMed ID: 16440780
[TBL] [Abstract][Full Text] [Related]
5. [Macular edema after an uncomplicated cataract surgery].
Jurecka T; Bátková Z; Ventruba J
Cesk Slov Oftalmol; 2007 Jul; 63(4):262-73. PubMed ID: 17682606
[TBL] [Abstract][Full Text] [Related]
6. Ocular side effects in chronic myeloid leukemia patients treated with imatinib.
Breccia M; Gentilini F; Cannella L; Latagliata R; Carmosino I; Frustaci A; Alimena G
Leuk Res; 2008 Jul; 32(7):1022-5. PubMed ID: 18061664
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography evaluation of macular edema after phacoemulsification surgery with intracameral mydriatics.
Johansson M; Lundberg B; Behndig A
J Cataract Refract Surg; 2007 Aug; 33(8):1436-41. PubMed ID: 17662438
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib.
Woo SM; Huh CH; Park KC; Youn SW
J Dermatol; 2007 Oct; 34(10):724-6. PubMed ID: 17908148
[No Abstract] [Full Text] [Related]
9. Imatinib-associated hyperpigmentation, a side effect that should be recognized.
Mcpherson T; Sherman V; Turner R
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):82-3. PubMed ID: 18384557
[No Abstract] [Full Text] [Related]
10. Bilateral cystoid macular edema after phacoemulsification in post-laser in situ keratomileusis eyes.
Chalioulias K; Tsaloumas M
J Cataract Refract Surg; 2007 Jun; 33(6):1101-3. PubMed ID: 17531708
[TBL] [Abstract][Full Text] [Related]
11. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.
Galanopoulos A; Papadhimitriou SI; Kritikou-Griva E; Georgiakaki M; Anagnostopoulos NI
Ann Hematol; 2009 Mar; 88(3):281-2. PubMed ID: 18726593
[No Abstract] [Full Text] [Related]
13. Imatinib-induced erythrodermia in a patient with chronic myeloid leukemia.
Oztas P; Erbasi S; Lenk N; Polat M; Han O; Artuz F; Alli N
Acta Derm Venereol; 2006; 86(2):174-5. PubMed ID: 16648930
[No Abstract] [Full Text] [Related]
14. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery.
Almeida DR; Johnson D; Hollands H; Smallman D; Baxter S; Eng KT; Kratky V; ten Hove MW; Sharma S; El-Defrawy S
J Cataract Refract Surg; 2008 Jan; 34(1):64-9. PubMed ID: 18165083
[TBL] [Abstract][Full Text] [Related]
15. Imatinib-associated neutropenia may not be overcome by filgrastim treatment in patients with blastic phase of chronic myeloid leukaemia.
Zaucha JM; Wyrowinska E; Prejzner W; Calbecka M; Hellmann A
Clin Lab Haematol; 2006 Jun; 28(3):208-10. PubMed ID: 16706939
[TBL] [Abstract][Full Text] [Related]
16. Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
Thia TJ; Tan HH; Chuah TH; Chow WC; Lui HF
Singapore Med J; 2008 Mar; 49(3):e86-9. PubMed ID: 18362995
[TBL] [Abstract][Full Text] [Related]
17. Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate loss.
François H; Coppo P; Hayman JP; Fouqueray B; Mougenot B; Ronco P
Am J Kidney Dis; 2008 Feb; 51(2):298-301. PubMed ID: 18215707
[TBL] [Abstract][Full Text] [Related]
18. Cardiac events in imatinib mesylate-treated chronic myeloid leukemia patients: A single institution experience.
Breccia M; Cannella L; Frustaci A; Stefanizzi C; Levi A; Alimena G
Leuk Res; 2008 May; 32(5):835-6. PubMed ID: 17905431
[No Abstract] [Full Text] [Related]
19. Cutaneous lichenoid eruption caused by imatinib mesylate in a Japanese patient with chronic myeloid leukaemia.
Kawakami T; Kawanabe T; Soma Y
Acta Derm Venereol; 2009; 89(3):325-6. PubMed ID: 19479144
[No Abstract] [Full Text] [Related]
20. Imatinib mesylate as a cause of acute liver failure.
Cross TJ; Bagot C; Portmann B; Wendon J; Gillett D
Am J Hematol; 2006 Mar; 81(3):189-92. PubMed ID: 16493605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
